Copyright: ©Author(s) 2026.
World J Psychiatry. Nov 19, 2026; 16(11): 123981
Published online Nov 19, 2026. doi: 10.5498/wjp.123981
Published online Nov 19, 2026. doi: 10.5498/wjp.123981
Table 2 Baseline characteristics of participants with sleep problems stratified by tertiles of the triglyceride-glucose index combined with a body shape index
| Characteristic | TyG-ABSI | P value | ||
| T1 (≤ 6.66) | T2 (< 7.34) | T3 (≥ 7.34) | ||
| Participant | 217 | 334 | 421 | |
| Age (years) | 42.45 (39.87-45.03) | 51.05 (49.13-52.98) | 56.32 (54.83-57.80) | < 0.0001 |
| Gender | < 0.0001 | |||
| Male | 31.76 (24.00-40.67) | 50.49 (44.49-56.49) | 64.37 (57.28-70.87) | |
| Female | 68.24 (59.33-76.00) | 49.51 (43.51-55.51) | 35.63 (29.13-42.72) | |
| Race/ethnicity | < 0.0001 | |||
| Non-Hispanic White | 67.78 (61.29-73.66) | 71.86 (66.02-77.04) | 81.14 (76.12-85.30) | |
| Non-Hispanic Black | 20.76 (16.08-26.39) | 11.93 (9.14-15.42) | 4.87 (3.30-7.12) | |
| Mexican American | 5.04 (2.85-8.76) | 4.72 (2.78-7.91) | 4.67 (2.96-7.32) | |
| Other Hispanic | 3.49 (1.98-6.06) | 5.47 (3.59-8.25) | 4.30 (2.71-6.78) | |
| Other race | 2.92 (1.27-6.59) | 6.03 (3.71-9.65) | 5.02 (3.01-8.26) | |
| Education level | 0.1148 | |||
| Under Highschool | 1.66 (0.67-4.05) | 6.65 (3.93-11.03) | 6.78 (4.92-9.27) | |
| Highschool | 30.67 (23.23-39.28) | 33.05 (26.69-40.10) | 36.00 (29.80-42.71) | |
| Above Highschool | 67.66 (59.09-75.19) | 60.30 (52.28-67.81) | 57.21 (50.29-63.87) | |
| Poverty income ratio | 2.95 (2.71-3.18) | 2.97 (2.69-3.25) | 2.82 (2.57-3.08) | 0.6353 |
| Smoke | < 0.0001 | |||
| Never | 55.46 (46.85-63.76) | 45.93 (37.86-54.22) | 34.44 (27.84-41.69) | |
| Former | 20.01 (13.87-27.97) | 24.09 (18.92-30.14) | 38.22 (32.24-44.58) | |
| Now | 21.87 (16.56-28.31) | 28.91 (23.41-35.12) | 27.30 (22.15-33.14) | |
| Alcohol use | 0.0017 | |||
| Never | 11.77 (7.24-18.58) | 8.87 (5.15-14.87) | 10.79 (7.78-14.78) | |
| Former | 10.59 (6.51-16.77) | 22.62 (17.49-28.73) | 26.00 (20.30-32.65) | |
| Mild | 26.14 (19.63-33.89) | 31.14 (23.17-40.41) | 33.38 (27.05-40.38) | |
| Moderate | 26.38 (18.33-36.40) | 15.40 (10.62-21.79) | 11.61 (7.88-16.77) | |
| Heavy | 18.06 (12.16-25.96) | 18.28 (13.49-24.29) | 12.92 (9.08-18.06) | |
| Diastolic blood pressure (mmHg) | 68.90 (67.17-70.64) | 70.05 (68.49-71.62) | 70.73 (69.02-72.45) | 0.3273 |
| Systolic blood pressure (mmHg) | 117.80 (115.78-119.82) | 120.46 (118.16-122.76) | 126.59 (124.74-128.43) | < 0.0001 |
| ALT (U/L) | 22.39 (20.31-24.47) | 25.33 (23.46-27.20) | 31.22 (28.25-34.19) | 0.0001 |
| AST (U/L) | 23.96 (21.77-26.14) | 26.46 (23.22-29.70) | 28.97 (26.70-31.24) | 0.0134 |
| Blood urea nitrogen (mg/dL) | 13.16 (12.32-13.99) | 13.11 (12.53-13.70) | 14.96 (14.34-15.58) | < 0.0001 |
| Creatinine (mg/dL) | 0.88 (0.85-0.91) | 0.91 (0.88-0.95) | 0.99 (0.94-1.03) | 0.0002 |
| Bilirubin, total (mg/dL) | 0.73 (0.67-0.79) | 0.72 (0.68-0.76) | 0.73 (0.68-0.77) | 0.9687 |
| Cholesterol, total (mg/dL) | 181.50 (174.02-188.98) | 194.00 (188.25-199.75) | 195.96 (189.73-202.20) | 0.0222 |
| Direct HDL-cholesterol (mg/dL) | 59.62 (56.80-62.45) | 53.43 (51.24-55.63) | 43.80 (42.29-45.32) | < 0.0001 |
| LDH (U/L) | 129.37 (124.38-134.37) | 132.71 (128.40-137.03) | 132.43 (128.78-136.08) | 0.5165 |
| Triglycerides (mg/dL) | 73.57 (66.58-80.55) | 114.43 (107.92-120.94) | 226.72 (190.74-262.69) | < 0.0001 |
| Diabetes mellitus | < 0.0001 | |||
| No | 83.02 (77.27-87.55) | 63.15 (57.00-68.90) | 34.35 (28.13-41.17) | |
| Diabetes mellitus | 9.42 (6.15-14.16) | 13.91 (9.85-19.29) | 49.77 (43.02-56.53) | |
| Impaired fasting glycaemia | 2.03 (0.80-5.06) | 12.03 (7.97-17.76) | 9.71 (6.78-13.73) | |
| Impaired glucose tolerance | 5.53 (2.91-10.27) | 10.91 (7.19-16.22) | 6.16 (3.72-10.04) | |
| Hyperlipidemia | < 0.0001 | |||
| No | 42.98 (35.28-51.03) | 18.26 (13.59-24.08) | 6.47 (3.95-10.44) | |
| Yes | 57.02 (48.97-64.72) | 81.74 (75.92-86.41) | 93.53 (89.56-96.05) | |
| Atherosclerotic cardiovascular disease | 0.0001 | |||
| No | 91.71 (86.19-95.14) | 85.37 (79.93-89.52) | 73.59 (66.71-79.48) | |
| Yes | 8.29 (4.86-13.81) | 14.63 (10.48-20.07) | 26.41 (20.52-33.29) | |
| Congestive heart failure | 0.0361 | |||
| No | 97.68 (91.30-99.41) | 92.50 (88.18-95.32) | 89.97 (85.65-93.09) | |
| Yes | 2.32 (0.59-8.70) | 7.50 (4.68-11.82) | 10.03 (6.91-14.35) | |
| Myocardial infarction | 0.0001 | |||
| No | 96.82 (93.77-98.40) | 92.55 (88.00-95.47) | 86.79 (81.91-90.51) | |
| Yes | 3.18 (1.60-6.23) | 7.45 (4.53-12.00) | 13.21 (9.49-18.09) | |
| Angina pectoris | 0.0004 | |||
| No | 98.25 (95.92-99.26) | 95.83 (92.84-97.60) | 90.84 (86.86-93.71) | |
| Yes | 1.75 (0.74-4.08) | 4.17 (2.40-7.16) | 9.16 (6.29-13.14) | |
| Sleep duration (hours) | 6.20 (5.90-6.49) | 6.40 (6.20-6.59) | 6.61 (6.40-6.82) | 0.0904 |
- Citation: Zhang YC, Yu ZZ, Zheng WT, Wang C. Triglyceride-glucose index combined with a body shape index in relation to sleep problems and sleep duration. World J Psychiatry 2026; 16(11): 123981
- URL: https://www.wjgnet.com/2220-3206/full/v16/i11/123981.htm
- DOI: https://dx.doi.org/10.5498/wjp.123981